+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Veterinary CRO Market by Service Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027

  • ID: 5237500
  • Report
  • November 2020
  • Region: Global
  • 236 pages
  • Allied Analytics LLP

Contract research organizations (CROs) are companies that help assist in research & development and/or other services related to newer products for sponsor companies. Sponsors frequently outsource their product development functions to independent service providers to augment their practice of a flexible cost structure and overcome the requirement to maintain redundant development proficiencies globally. Clinical, regulatory, and therapeutic expertise of CROs help improvise the total cost of product development and market entry of a new product. As a result, CROs have emerged as competent providers of an increasing array of value-added services for veterinary companies and are expected to continue to play a vital role in the in vivo studies involving companion animals. Furthermore, veterinary CROs support sponsor companies by providing assistance in veterinary clinical trial development, strategic regulatory affairs expertise, project management support for an extensive range of veterinary products, new product development, lifecycle management of existing marketing authorizations (MA), and veterinary good clinical practice (GCP) regulatory management. Veterinary CROs also offer services such as strategic advice on data management & statistical analysis, post-marketing support, gap analysis, as well as pharmacovigilance. These services are often used by veterinary researchers and medicine manufacturers for newer product development along with testing the safety & efficacy of veterinary drugs.

Accordingly, the global veterinary CRO market is poised to reach $1,260.5 million in 2027 from $771.8 million in 2019, and is expected to register a CAGR of 7.7% during the forecast period. The growth rate is majorly attributed to the surge in ownership of companion animals and the rise in animal health expenditure. Furthermore, other factors such as increase in global prevalence of diseases among companion animals and a surge in the R&D activities among veterinary medicine manufacturers act as key development factors that contribute toward the growth of the market. Nevertheless, lack of standardization in veterinary CROs is anticipated to hinder the market growth. Conversely, awareness associated with animal healthcare is on the rise as pet owners are more concerned about health and diseases of their companion animals. This increase in awareness related to animal healthcare across the globe is expected to provide profitable opportunities for key industry players in the market during the forecast period. Furthermore, presence of associations and NGOs that work toward spreading awareness related to animal healthcare are predicted to expose newer possibilities for growth of veterinary CROs market.

On the other hand, COVID-19 pandemic has greatly disrupted ongoing activities in the veterinary sector. Cost constraints on the entire animal healthcare industry, owing to economic slowdown due to the pandemic has imposed limitations on R&D finances of veterinary companies and has led companies to outsource these activities to veterinary CROs, consequently supplementing the market growth. Moreover, the susceptibility of domesticated animals to SARS-CoV-2 along with reported cases in cats and dogs have raised concerns regarding the infection to emerge as a disease in animals in coming years. Accordingly, there is a substantial increase in R&D activities for the development of COVID-19 veterinary vaccines and antiviral drugs. This has immensely heightened demand for companion animals such as cats for research purposes. Several clinical trials around the globe are currently investigated, which drives demand for such animals.

The research study segments the global veterinary CRO market into service type, animal type, indication, and region. On the basis of service type, the market is divided into clinical trials, toxicology, market authorization & regulatory support, and others. By animal type, it is classified into dogs, cats, and others. Depending on indication, it is categorized into oncology, infectious disease, neurology, and others. Region wise, it is analyzed across North America (the U.S, Canada, and Mexico) and Europe (Germany, France, Italy, Spain, the UK, and rest of Europe), Asia-Pacific (Japan, China, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global Veterinary CRO market is provided.
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

By Service Type

  • Clinical Trials
  • Toxicology
  • Market Authorization & Regulatory Support
  • Others

By Animal Type

  • Dogs
  • Cats
  • Others

By Indication

  • Oncology
  • Infectious Disease
  • Neurology
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Charles River Laboratories, Inc.
  • Clinvet
  • KLIFOVET AG
  • Löhlein & Wolf Vet Research
  • Oncovet Clinical Research
  • ONDAX Scientific
  • Triveritas
  • Veterinary Research Management (VRM) Ltd
  • VetPharm, Inc.
  • VETSPIN SRL
Note: Product cover images may vary from those shown
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled in the Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models

Chapter 2: Executive Summary
2.1. Key Findings of the Study
2.2. CXO Perspective

Chapter 3: Market Overview
3.1. Market Definition and Scope
3.1.1. Top Impacting Factors
3.1.2. Top Investment Pockets
3.2. Key Forces Shaping Veterinary Cro Industry/ Market
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threat of New Entrants
3.2.4. Threat of Substitutes
3.2.5. Intensity of Competitive Rivalry
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Surge in Ownership of Companion Animals
3.3.1.2. Rise in Animal Health Expenditure
3.3.1.3. Increase in Prevalence of Diseases Among Companion Animals
3.3.2. Restraint
3.3.2.1. Lack of Standardization in Veterinary Cros
3.3.3. Opportunity
3.3.3.1. Surge in Awareness Related to Animal Healthcare
3.3.4. Impact Analysis
3.4. Covid-19 Impact Analysis on the Market

Chapter 4: Veterinary Cro Market, by Service Type
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Clinical Trials
4.2.1. Key Market Trends and Growth Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Analysis, by Country
4.3. Toxicology
4.3.1. Key Market Trends and Growth Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.3. Market Analysis, by Country
4.4. Market Authorization and Regulatory Support
4.4.1. Key Market Trends and Growth Opportunities
4.4.2. Market Size and Forecast, by Region
4.4.3. Market Analysis, by Country
4.5. Others
4.5.1. Key Market Trends and Growth Opportunities
4.5.2. Market Size and Forecast, by Region
4.5.3. Market Analysis, by Country

Chapter 5: Veterinary Cro Market, by Animal Type
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Dogs
5.2.1. Market Size and Forecast, by Region
5.2.2. Market Analysis, by Country
5.3. Cats
5.3.1. Market Size and Forecast, by Region
5.3.2. Market Analysis, by Country
5.4. Others
5.4.1. Market Size and Forecast, by Region
5.4.2. Market Analysis, by Country

Chapter 6: Veterinary Cro Market, by Indication
6.1. Overview
6.1.1. Market Size and Forecast
6.2. Oncology
6.2.1. Market Size and Forecast, by Region
6.2.2. Market Analysis, by Country
6.3. Infectious Disease
6.3.1. Market Size and Forecast, by Region
6.3.2. Market Analysis, by Country
6.4. Neurology
6.4.1. Market Size and Forecast, by Region
6.4.2. Market Analysis, by Country
6.5. Others
6.5.1. Market Size and Forecast, by Region
6.5.2. Market Analysis, by Country

Chapter 7: Veterinary Cro Market, by Region
7.1. Overview
7.1.1. Market Size and Forecast
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. North America Market Size and Forecast, by Service Type
7.2.3. North America Market Size and Forecast, by Animal Type
7.2.4. North America Market Size and Forecast, by Indication
7.2.5. Market Analysis by Country
7.2.5.1. U.S.
7.2.5.1.1. U.S. Market Size and Forecast, by Service Type
7.2.5.1.2. U.S. Market Size and Forecast, by Animal Type
7.2.5.1.3. U.S. Market Size and Forecast, by Indication
7.2.5.2. Canada
7.2.5.2.1. Canada Market Size and Forecast, by Service Type
7.2.5.2.2. Canada Market Size and Forecast, by Animal Type
7.2.5.2.3. Canada Market Size and Forecast, by Indication
7.2.5.3. Mexico
7.2.5.3.1. Mexico Market Size and Forecast, by Service Type
7.2.5.3.2. Mexico Market Size and Forecast, by Animal Type
7.2.5.3.3. Mexico Market Size and Forecast, by Indication
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Europe Market Size and Forecast, by Service Type
7.3.3. Europe Market Size and Forecast, by Animal Type
7.3.4. Europe Market Size and Forecast, by Indication
7.3.5. Market Analysis by Country
7.3.5.1. Germany
7.3.5.1.1. Germany Market Size and Forecast, by Service Type
7.3.5.1.2. Germany Market Size and Forecast, by Animal Type
7.3.5.1.3. Germany Market Size and Forecast, by Indication
7.3.5.2. France
7.3.5.2.1. France Market Size and Forecast, by Service Type
7.3.5.2.2. France Market Size and Forecast, by Animal Type
7.3.5.2.3. France Market Size and Forecast, by Indication
7.3.5.3. UK
7.3.5.3.1. UK Market Size and Forecast, by Service Type
7.3.5.3.2. UK Market Size and Forecast, by Animal Type
7.3.5.3.3. UK Market Size and Forecast, by Indication
7.3.5.4. Italy
7.3.5.4.1. Italy Market Size and Forecast, by Service Type
7.3.5.4.2. Italy Market Size and Forecast, by Animal Type
7.3.5.4.3. Italy Market Size and Forecast, by Indication
7.3.5.5. Spain
7.3.5.5.1. Spain Market Size and Forecast, by Service Type
7.3.5.5.2. Spain Market Size and Forecast, by Animal Type
7.3.5.5.3. Spain Market Size and Forecast, by Indication
7.3.5.6. Rest of Europe
7.3.5.6.1. Rest of Europe Market Size and Forecast, by Service Type
7.3.5.6.2. Rest of Europe Market Size and Forecast, by Animal Type
7.3.5.6.3. Rest of Europe Market Size and Forecast, by Indication
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Asia-Pacific Market Size and Forecast, by Service Type
7.4.3. Asia-Pacific Market Size and Forecast, by Animal Type
7.4.4. Asia-Pacific Market Size and Forecast, by Indication
7.4.5. Market Analysis by Country
7.4.5.1. Japan
7.4.5.1.1. Japan Market Size and Forecast, by Service Type
7.4.5.1.2. Japan Market Size and Forecast, by Animal Type
7.4.5.1.3. Japan Market Size and Forecast, by Indication
7.4.5.2. China
7.4.5.2.1. China Market Size and Forecast, by Service Type
7.4.5.2.2. China Market Size and Forecast, by Animal Type
7.4.5.2.3. China Market Size and Forecast, by Indication
7.4.5.3. Australia
7.4.5.3.1. Australia Market Size and Forecast, by Service Type
7.4.5.3.2. Australia Market Size and Forecast, by Animal Type
7.4.5.3.3. Australia Market Size and Forecast, by Indication
7.4.5.4. Rest of Asia-Pacific
7.4.5.4.1. Rest of Asia-Pacific Market Size and Forecast, by Service Type
7.4.5.4.2. Rest of Asia-Pacific Market Size and Forecast, by Animal Type
7.4.5.4.3. Rest of Asia-Pacific Market Size and Forecast, by Indication
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. LAMEA Market Size and Forecast, by Service Type
7.5.3. LAMEA Market Size and Forecast, by Animal Type
7.5.4. LAMEA Market Size and Forecast, by Indication
7.5.5. Market Analysis by Country
7.5.5.1. Brazil
7.5.5.1.1. Brazil Market Size and Forecast, by Service Type
7.5.5.1.2. Brazil Market Size and Forecast, by Animal Type
7.5.5.1.3. Brazil Market Size and Forecast, by Indication
7.5.5.2. South Africa
7.5.5.2.1. South Africa Market Size and Forecast, by Service Type
7.5.5.2.2. South Africa Market Size and Forecast, by Animal Type
7.5.5.2.3. South Africa Market Size and Forecast, by Indication
7.5.5.3. Saudi Arabia
7.5.5.3.1. Saudi Arabia Market Size and Forecast, by Service Type
7.5.5.3.2. Saudi Arabia Market Size and Forecast, by Animal Type
7.5.5.3.3. Saudi Arabia Market Size and Forecast, by Indication
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Rest of LAMEA Market Size and Forecast, by Service Type
7.5.5.4.2. Rest of LAMEA Market Size and Forecast, by Animal Type
7.5.5.4.3. Rest of LAMEA Market Size and Forecast, by Indication

Chapter 8: Competitive Landscape
8.1. Introduction
8.1.1. Market Player Positioning, 2019
8.2. Top Winning Strategies and Key Developments
8.3. Competitive Dashboard
8.4. Competitive Heatmap

Chapter 9: Company Profiles
9.1. Charles River Laboratories, Inc.
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Operating Business Segments
9.1.4. Service Portfolio
9.1.5. Business Performance
9.1.6. Key Strategic Moves and Developments
9.2. Clinvet
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Operating Business Segments
9.2.4. Service Portfolio
9.3. Klifovet AG
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Operating Business Segments
9.3.4. Service Portfolio
9.4. Löhlein & Wolf Vet Research
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Operating Business Segments
9.4.4. Service Portfolio
9.5. Oncovet Clinical Research
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Operating Business Segments
9.5.4. Service Portfolio
9.6. Ondax Scientific
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Operating Business Segments
9.6.4. Service Portfolio
9.7. Triveritas
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Operating Business Segments
9.7.4. Service Portfolio
9.8. Veterinary Research Management (Vrm) Ltd
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Operating Business Segments
9.8.4. Service Portfolio
9.9. Vetpharm, Inc.
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Operating Business Segments
9.9.4. Service Portfolio
9.10. Vetspin Srl
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Operating Business Segments
9.10.4. Service Portfolio
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll